AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Coniglu M 1mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Coniak Lifesciences

Salt Composition

Glimepiride (1mg) + Metformin (1000mg)

Overview Coniglu M 1mg/1000mg Tablet SR

GlucoTone SR 1mg/1000mg tablets are classified as antidiabetic medications. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. Administer GlucoTone SR with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a rapid-acting glucose source (e.g., juice, candy). Alcohol increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before starting treatment; pregnancy or breastfeeding necessitates prior medical consultation. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Coniglu M 1mg/1000mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Coniglu M 1mg/1000mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Coniglu M 1mg/1000mg Tablet SR. Ingest the tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.

Common Side effects of Coniglu M 1mg/1000mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Coniglu M 1mg/1000mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Coniglu M 1mg/1000mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with food.

How Coniglu M 1mg/1000mg Tablet SR works:

Coniglu M 1mg/1000mg sustained-release tablets contain glimepiride and metformin, two agents that manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Coniglu M 1mg/1000mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Coniglu M 1mg/1000mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Coniglu M tablets (1mg/1000mg) are contraindicated for use while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Coniglu M 1mg/1000mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Regular kidney function monitoring is recommended during treatment. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Coniglu M 1mg/1000mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Low initial doses are typically prescribed for those with mild to moderate hepatic dysfunction; however, the medication is contraindicated in patients exhibiting severe liver disease.

What if you forget to take Coniglu M 1mg/1000mg Tablet SR :

Should you forget a Coniglu M 1mg/1000mg Tablet SR dose, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Coniglu M 1mg/1000mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Coniglu M 1mg/1000mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Coniglu M 1mg/1000mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Coniglu M 1mg/1000mg Tablet SR and seek immediate medical attention.
Coniglu M 1mg/1000mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Coniglu M 1mg/1000mg SR tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Coniglu M 1mg/1000mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), and urinary or cognitive issues. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Coniglu M 1mg/1000mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Coniglu M 1mg/1000mg SR tablets with alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Coniglu M 1mg/1000mg Tabl...
77
MRP 89
13% off